Evidence map›Paper›PMID 29581751›Full record

ArticleExperimental and therapeutic medicine2018

Tumor suppressor miR-211-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.

Jing Quan, Xiang Pan, Tao He, Canbin Lin, Yulin Lai, Peijie Chen, Zeng Zhang, Shangqi Yang, Tao Wang, Yongqing Lai

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Florfenicol induces renal toxicity in chicks by promoting oxidative stress and apoptosis.Environmental science and pollution research international · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jing QuanDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Xiang PanDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Tao HeDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Canbin LinDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Yulin LaiDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Peijie ChenDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Zeng ZhangDepartment of Urology, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Shangqi YangDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Tao WangDepartment of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Yongqing LaiDepartment of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence has demonstrated that microRNA (miRNA) serve an important role in the tumorigenesis of various types of cancer, such as renal cell carcinoma (RCC). The expression of miR-211-5p has been detected in RCC tissue by microarray profiling. However, studies regarding miR-211-5p and RCC remain rare. In the present study, the expression of miR-211-5p in RCC tissues and cell lines was revealed to be downregulated by reverse transcription-quantitative polymerase chain reaction analyses. The present results also revealed that the upregulation or downregulation of miR-211-5p inhibited or promoted, respectively, RCC cell proliferation, migration and invasion. In addition, the upregulation or downregulation of miR-211-5p induced or inhibited, respectively, RCC cell apoptosis. However, the present study only identified that downregulation of miR-211-5p promoted 786O and ACHN cell viability. The above results suggest that miR-211-5p may be a tumor suppressor in the tumorigenesis of RCC and may be a potential therapeutic target for RCC in the future. Further research should focus on the underlying mechanism of miR-211-5p in RCC and on investigating the possible use of miR-211-5p as a biomarker for RCC.

Indexed as

microRNAmiR-211-5prenal cell carcinomatumor suppressor

Identifiers

PMID29581751
PMCPMC5863605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.